Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAG | P20916 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KLK7 | P49862 | 1/20 | 0.33 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.33 |
| ▸ | HRAS | P01112 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15513804 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL10545105 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL11565600 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL10543455 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL6833949 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL8332499 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL10542172 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL14612249 | 0.93 | L3MBTL1 (0.74) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL22607623 | 0.93 | L3MBTL1 (0.74) | L3MBTL1KMT2AMEN1SELPALDH1A1 | |
| SCHEMBL8334325 | 0.93 | L3MBTL1 (0.74) | L3MBTL1KMT2AMEN1SELPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140073589-A1 | Amphetamine Prodrugs | SHIRE AG (CH) | 2014-03-13 | — | — | US | disclosed |
| US-5750665-A | Preparation of glucosaminyl muramic acid derivatives | ENDOREX CORPORATION | 1998-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140073589-A1 | Amphetamine Prodrugs | SLC6A2, SLC6A3, TAAR5 | L3MBTL1 2286/4885KMT2A 526/4885MEN1 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.